Apo-Emtricitabine-Tenofovir 300 mg

APO-EMTRICITABINE-TENOFOVIR 300 MG tablets combine emtricitabine and tenofovir disoproxil fumarate for HIV treatment. This oral medication is designed to support antiviral therapy. Learn about its uses and effects.

APO-EMTRICITABINE-TENOFOVIR 300 MG tablets are used in the management of HIV infection. This combination therapy is intended to help control the virus and improve immune function. The medication is typically part of a broader treatment plan, often referred to as antiretroviral therapy (ART).

Common effects of APO-EMTRICITABINE-TENOFOVIR 300 MG tablets may include nausea, diarrhea, and headache. Some individuals might experience dizziness or fatigue. These effects can vary and are not experienced by everyone who takes the medication.

APO-EMTRICITABINE-TENOFOVIR 300 MG tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding its use. This medication may not be suitable for everyone, particularly those with certain kidney conditions or other health issues.

APO-EMTRICITABINE-TENOFOVIR 300 MG tablets can interact with other medications, including certain antiviral drugs and medications that affect kidney function. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.